<DOC>
	<DOC>NCT00601484</DOC>
	<brief_summary>The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.</brief_summary>
	<brief_title>An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis</brief_title>
	<detailed_description />
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis, Interstitial</mesh_term>
	<criteria>Male and female adults at least 18 years of age; Moderate to severe interstitial cystitis, with a mean pain intensity score above a predefined level. Less than 6 months since onset of interstitial cystitis symptoms; History of recurrent urinary tract infections, or genitourinary cancer; History of hepatitis B, C or human immunodeficiency virus (HIV); Use of certain drugs given into the bladder up to 1 month prior to study entry.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Painful Bladder Syndrome, monoclonal antibody</keyword>
</DOC>